In addition, the expression of SETD1A was obviously enhanced in hepatocellular carcinoma cell lines and tumor tissues and SETD1A knockdown enhanced sorafenib-induced proliferation inhibition and cellular apoptosis [15]. The gene discussed is SETD1A; the disease is neoplasm.